Literature DB >> 8962045

Neurodegenerative diseases and transglutaminase.

L Lorand1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8962045      PMCID： PMC34481          DOI： 10.1073/pnas.93.25.14310

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  56 in total

Review 1.  The keratinocyte as differentiated cell type.

Authors:  H Green
Journal:  Harvey Lect       Date:  1980

2.  Transglutaminase C in cerebellar granule neurons: regulation and localization of substrate cross-linking.

Authors:  M J Perry; S A Mahoney; L W Haynes
Journal:  Neuroscience       Date:  1995-04       Impact factor: 3.590

3.  Alterations in neural intermediate filament organization: functional implications and the induction of pathological changes related to motor neuron disease.

Authors:  K Straube-West; P A Loomis; P Opal; R D Goldman
Journal:  J Cell Sci       Date:  1996-09       Impact factor: 5.285

4.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

5.  Regulation of transglutaminase activity by GTP in digitonin permeabilized Yoshida tumor cells.

Authors:  C M Bergamini; M Signorini; L Caselli; P Melandri
Journal:  Biochem Mol Biol Int       Date:  1993-07

6.  Huntingtin-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase.

Authors:  X J Li; A H Sharp; S H Li; T M Dawson; S H Snyder; C A Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

8.  Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p.

Authors:  S Nagafuchi; H Yanagisawa; K Sato; T Shirayama; E Ohsaki; M Bundo; T Takeda; K Tadokoro; I Kondo; N Murayama
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

9.  Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity.

Authors:  K E Achyuthan; C S Greenberg
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

10.  Covalent modification of synapsin I by a tetanus toxin-activated transglutaminase.

Authors:  F Facchiano; F Benfenati; F Valtorta; A Luini
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157
View more
  7 in total

1.  Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity.

Authors:  Shenping Liu; Richard A Cerione; Jon Clardy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

2.  Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.

Authors:  A J Cooper; K R Sheu; J R Burke; O Onodera; W J Strittmatter; A D Roses; J P Blass
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

3.  Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei.

Authors:  M V Karpuj; H Garren; H Slunt; D L Price; J Gusella; M W Becher; L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 4.  Aggregation of expanded huntingtin in the brains of patients with Huntington disease.

Authors:  Guylaine Hoffner; Sylvie Souès; Philippe Djian
Journal:  Prion       Date:  2007 Jan-Mar       Impact factor: 3.931

5.  Amyloid-like protein inclusions in tobacco transgenic plants.

Authors:  Anna Villar-Piqué; Raimon Sabaté; Oriol Lopera; Jordi Gibert; Josep Maria Torne; Mireya Santos; Salvador Ventura
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

Review 6.  Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.

Authors:  Barry W Festoff; Zhiming Suo; Bruce A Citron
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Transglutaminase type II plays a protective role in hepatic injury.

Authors:  Roberta Nardacci; Oreste Lo Iacono; Fabiola Ciccosanti; Laura Falasca; Maria Addesso; Alessandra Amendola; Giorgio Antonucci; Antonio Craxì; Gian Maria Fimia; Valentina Iadevaia; Gerry Melino; Luigi Ruco; Guido Tocci; Giuseppe Ippolito; Mauro Piacentini
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.